FETO-MATERNAL OUTCOMES OF THROMBOCYTOPENIA IN PREGNANCY

Abstract

The purpose of this study was to assess the feto-maternal consequences of thrombocytopenia during pregnancy and to find meaningful associations between bad outcomes and maternal risk factors.

Study design:

Descriptive cross-sectional study. This study was carried out at department of Obstetrics and Gynecology, CMH Gujranwala from April 2025 till 15 July 2025.

Methods and materials:

Convenience sampling was used to register 100 pregnant women in CMH Gujranwala between the ages of 18 and 40 who had a gestational age of more than 24 weeks and a diagnosis of thrombocytopenia (platelet count <150×10³/mm³). Pancytopenia and persistent systemic diseases were among the exclusion criteria. Demographic information, reservation status, way of life, and thrombocytopenia history were documented. Preterm birth, low birth weight, and neonatal thrombocytopenia were among the fetal results, while anemia, abruption, and intrauterine death (IUD) were among the maternal outcomes. To evaluate relationships with p ≤ 0.05 deemed significant, the chi-square test was utilized.

Results:

The average gestational age was 28.22 ± 6.06 weeks, and the average maternal age was 28.53 ± 6.77 years. The most common maternal complications were anemia (80%), placental abruption (22%), and IUD (15%). Half of the newborns had neonatal thrombocytopenia. Un-booked status was significantly associated with premature birth (p = 0.041), anemia (p < 0.001), and IUD (p < 0.001). Negative outcomes were also substantially associated with a sedentary lifestyle and a past or family history of thrombocytopenia.

Conclusion:

Pregnancy-related thrombocytopenia is associated with major problems for both the mother and the unborn child. Prenatal booking, routine monitoring, and early identification are essential for minimizing negative effects.